| Name | 6-chloroimidazo[2,1-b][1,3]thiazole-5-carboxylic acid |
|---|---|
| Synonyms |
F2124-0514
6-chloro-imidazo[2,1-b]thiazole-5-carboxylic acid |
| Density | 1.91g/cm3 |
|---|---|
| Molecular Formula | C6H3ClN2O2S |
| Molecular Weight | 202.61800 |
| Exact Mass | 201.96000 |
| PSA | 82.84000 |
| LogP | 1.74740 |
| Index of Refraction | 1.822 |
| HS Code | 2934100090 |
|---|
|
~%
24918-20-5 |
| Literature: Actelion Phamaceuticals Ltd. Patent: US2010/16401 A1, 2010 ; Location in patent: Page/Page column 47 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |